HomeITOS • NASDAQ
add
iTeos Therapeutics Inc
Previous close
$10.04
Day range
$9.96 - $10.10
Year range
$4.80 - $18.13
Market cap
383.50M USD
Avg Volume
2.20M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 39.53M | -14.87% |
Net income | -34.61M | 9.43% |
Net profit margin | — | — |
Earnings per share | -0.80 | 25.23% |
EBITDA | -39.20M | 15.01% |
Effective tax rate | -3.28% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 520.37M | 15.86% |
Total assets | 658.87M | 4.62% |
Total liabilities | 95.45M | 7.77% |
Total equity | 563.42M | — |
Shares outstanding | 38.27M | — |
Price to book | 0.68 | — |
Return on assets | -14.68% | — |
Return on capital | -16.98% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -34.61M | 9.43% |
Cash from operations | -33.76M | -4.21% |
Cash from investing | 47.69M | 168.52% |
Cash from financing | 32.00K | 45.45% |
Net change in cash | 14.42M | 113.79% |
Free cash flow | -22.07M | 43.94% |
About
Founded
2011
Headquarters
Website
Employees
173
